Mork Capital Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.44M Hold
13,960
0.92% 40
2026
Q1
$1M Sell
13,960
-8,540
-38% -$658K 0.71% 77
2025
Q4
$1.79M Hold
22,500
1.09% 26
2025
Q3
$1.7M Hold
22,500
1.17% 23
2025
Q2
$1.55M Hold
22,500
1.13% 27
2025
Q1
$1.52M Hold
22,500
1.19% 22
2024
Q4
$1.01M Buy
+22,500
New +$1.26M 0.66% 77
2018
Q4
Sell
-13,700
Closed -$1.08M 119
2018
Q3
$1.08M Hold
13,700
0.87% 59
2018
Q2
$882K Hold
13,700
0.78% 73
2018
Q1
$852K Hold
13,700
0.82% 76
2017
Q4
$993K Buy
+13,700
New +$996K 0.66% 81

Other funds holding CVS

Mork Capital Management's CVS Position: Q2 2026 in Review

Mork Capital Management held its CVS Health (CVS) position steady in Q2 2026 at 13,960 shares worth $1.44M. The position accounts for 0.92% of the portfolio, ranked #40.

Mork Capital Management first reported a position in CVS in Q4 2017 and has held it in 11 quarters since. The position peaked at $1.79M in Q4 2025. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Mork Capital Management held 13,960 shares of CVS Health worth $1.44M as of Q2 2026.
  • Mork Capital Management left its CVS Health share count unchanged in Q2 2026.
  • CVS Health made up 0.92% of Mork Capital Management's portfolio in Q2 2026, its #40 holding.
  • Mork Capital Management first reported a position in CVS Health in Q4 2017 and has held it in 11 quarters since.
  • Mork Capital Management's CVS Health position peaked at $1.79M in Q4 2025.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Mork Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.